MAY HIGH CUT-OFF HAEMODIALYSIS STILL BE CONSIDERED BENEFICIAL IN THE TREATMENT OF ACUTE KIDNEY INJURY RELATED TO MULTIPLE MYELOMA?

被引：0
|
作者：
Alexandru, Simona [1 ]
Lopez Picasso, Maria [1 ]
Garcia-Puente Suarez, Laura [1 ]
Pizarro Sanchez, Maria Soledad [1 ]
Pampa Saico, Saul [1 ]
Poma Tapia, Marisol [1 ]
Barba, Raquel [2 ]
机构：
[1] Hosp Univ Rey Juan Carlos, Nephrol, Mostoles, Spain
[2] Hosp Univ Rey Juan Carlos, Internal Med, Mostoles, Spain
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
P0649
引用
收藏
页码：969 / 969
页数：1
相关论文
共 50 条
  • [21] HEMODIALYSIS WITH HIGH CUT-OFF FILTERS AND CHEMOTHERAPY FOR MULTIPLE MYELOMA PATIENTS WITH ACUTE RENAL FAILURE
    Alkadi, N.
    Dourdil, V.
    Bonafonte, E.
    Arango, L.
    Leza, D.
    Escobar, M. J.
    Romero, L. L.
    Olave, M. T.
    Palomera, L.
    HAEMATOLOGICA, 2014, 99 : 639 - 639
  • [22] Extended high cut-off haemodialysis for myeloma cast nephropathy in Auckland, 2008-2012
    Tan, Jasmine
    Lam-Po-Tang, Michael
    Hutchison, Colin A.
    De Zoysa, Janak R.
    NEPHROLOGY, 2014, 19 (07) : 432 - 435
  • [23] FREE LIGHT CHAINS (FLCs) REDUCTION ON ACUTE KIDNEY INJURY (AKI) IN MULTIPLE MYELOMA: CRITICAL ROLE OF HIGH CUT-OFF DIALYSIS MEMBRANES (HCO-HD)
    Buti, Elisa
    Dervishi, Egrina
    Bergesio, Franco
    Ghiandai, Giulia
    Mjeshtri, Anduela
    Paudice, Nunzia
    Caldini, Anna Lucia
    Nozzoli, Chiara
    Minetti, Enrico Eugenio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 395 - 395
  • [24] Aggregated serum free light chains may prevent adequate removal by high cut-off haemodialysis
    Harding, Stephen
    Provot, Francois
    Beuscart, Jean-Baptise
    Cook, Mark
    Bradwell, Arthur R.
    Stringer, Stephanie
    White, Darren
    Cockwell, Paul
    Hutchison, Colin A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (04) : 1438 - 1440
  • [25] Citrate Extended High Cut-Off Hemodiafiltration for Renal Recovery in Patients With Multiple Myeloma
    Pernat, Andreja Marn
    Medved, Bojan
    Gubensek, Jakob
    Premru, Vladimir
    Knap, Bojan
    Buturovic-Ponikvar, Jadranka
    Ponikvar, Rafael
    THERAPEUTIC APHERESIS AND DIALYSIS, 2016, 20 (03) : 251 - 255
  • [26] Acute renal failure in patients with myeloma: Experience with extended high cut-off hemodialysis
    Isabel Saez, Maria
    Camarero, Vanesa
    Rosales, Alejandro
    Hijazi, Badawi
    Jesus Izquierdo, Maria
    Labrador, Jorge
    Alvarez, Rodolfo
    Hermida, Julio
    Mercado, Veronica
    Dolores Badia, Maria
    de Toro, Raquel
    Gonzalez, Basilia
    Abaigar, Pedro
    NEFROLOGIA, 2017, 37 (04): : 429 - 431
  • [27] Extracorporeal light chain elimination: high cut-off (HCO) hemodialysis parallel to chemotherapy allows for a high proportion of renal recovery in multiple myeloma patients with dialysis-dependent acute kidney injury
    Heyne, Nils
    Denecke, Barbara
    Guthoff, Martina
    Oehrlein, Katharina
    Kanz, Lothar
    Haering, Hans-Ulrich
    Weisel, Katja C.
    ANNALS OF HEMATOLOGY, 2012, 91 (05) : 729 - 735
  • [28] Extracorporeal light chain elimination: high cut-off (HCO) hemodialysis parallel to chemotherapy allows for a high proportion of renal recovery in multiple myeloma patients with dialysis-dependent acute kidney injury
    Nils Heyne
    Barbara Denecke
    Martina Guthoff
    Katharina Oehrlein
    Lothar Kanz
    Hans-Ulrich Häring
    Katja C. Weisel
    Annals of Hematology, 2012, 91 : 729 - 735
  • [29] COST EFFECTIVENESS OF TREATMENT OF MULTIPLE MYELOMA WITH FILTERS HIGH CUT OFF
    Alvarez Lipe, Rafael
    Berni Weenekers, Ana
    Martin Azara, Pilar
    Bergasa Liberal, Beatriz
    Guerrero, Vanesa
    Vernet Perna, Patricia
    Martinez, Alba
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 1497 - 1497
  • [30] Pharmacokinetics of lenalidomide during high cut-off dialysis in a patient with multiple myeloma and renal failure
    Dao, Kim
    Lu, Yimin
    Peer, Cody J.
    Figg, William D.
    Stadelmann, Raphael
    Burnier, Michel
    Buclin, Thierry
    Kissling, Sebastien
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (01) : 215 - 218
12345